Annual Operating Expenses
$69.00 M
+$34.96 M+102.71%
December 31, 2021
Summary
- As of February 10, 2025, GMTX annual total operating expenses is $69.00 million, with the most recent change of +$34.96 million (+102.71%) on December 31, 2021.
- During the last 3 years, GMTX annual operating expenses has risen by +$34.96 million (+102.71%).
Performance
GMTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$3.74 M
-$3.50 M-48.34%
September 30, 2022
Summary
- As of February 10, 2025, GMTX quarterly total operating expenses is $3.74 million, with the most recent change of -$3.50 million (-48.34%) on September 30, 2022.
- Over the past year, GMTX quarterly operating expenses has dropped by -$14.71 million (-79.75%).
Performance
GMTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
GMTX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +102.7% | -79.8% |
| 3 y3 years | +102.7% | -61.2% |
| 5 y5 years | +102.7% | -61.2% |
GMTX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -78.9% | at low |
| 5 y | 5-year | at high | -50.7% | -79.7% | -290.8% |
| alltime | all time | at high | -50.7% | -79.7% | -290.8% |
Gemini Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $3.74 M(-48.3%) |
| Jun 2022 | - | $7.23 M(-52.3%) |
| Mar 2022 | - | $15.18 M(-14.5%) |
| Dec 2021 | $69.00 M | $17.74 M(-3.8%) |
| Sep 2021 | - | $18.45 M(+13.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $16.32 M(-1.0%) |
| Mar 2021 | - | $16.49 M(-331.2%) |
| Dec 2020 | $34.04 M | -$7.13 M(-189.7%) |
| Sep 2020 | - | $7.95 M(+19.2%) |
| Jun 2020 | - | $6.67 M(-30.8%) |
| Mar 2020 | - | $9.63 M |
FAQ
- What is Gemini Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Gemini Therapeutics?
- What is Gemini Therapeutics annual operating expenses year-on-year change?
- What is Gemini Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Gemini Therapeutics?
- What is Gemini Therapeutics quarterly operating expenses year-on-year change?
What is Gemini Therapeutics annual total operating expenses?
The current annual operating expenses of GMTX is $69.00 M
What is the all time high annual operating expenses for Gemini Therapeutics?
Gemini Therapeutics all-time high annual total operating expenses is $69.00 M
What is Gemini Therapeutics annual operating expenses year-on-year change?
Over the past year, GMTX annual total operating expenses has changed by +$34.96 M (+102.71%)
What is Gemini Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of GMTX is $3.74 M
What is the all time high quarterly operating expenses for Gemini Therapeutics?
Gemini Therapeutics all-time high quarterly total operating expenses is $18.45 M
What is Gemini Therapeutics quarterly operating expenses year-on-year change?
Over the past year, GMTX quarterly total operating expenses has changed by -$14.71 M (-79.75%)